Zelavespib dihydrochlorideProduct ingredient for Zelavespib
- Name
- Zelavespib dihydrochloride
- Drug Entry
- Zelavespib
Zelavespib (PU-H71) has been used in trials studying the treatment of LYMPHOMA, Solid Tumors, Metastatic Solid Tumor, and Myeloproliferative Neoplasms (MPN).
- Accession Number
- DBSALT003292
- Structure
- Synonyms
- 8-(6-iodobenzo[1,3]dioxol-5-ylsufanyl)-9-(3-isopropylamino propyl)adenine dihydrochloride
- UNII
- ZEO4G69K8S
- CAS Number
- 2249878-50-8
- External Links
- Not Available
- Predicted Properties
- Not Available